Omnicell
OMCL
377 hedge funds and large institutions have $6.71B invested in Omnicell in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 130 increasing their positions, 146 reducing their positions, and 40 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 9 → 12 (+3)
18% more capital invested
Capital invested by funds: $5.7B → $6.71B (+$1.01B)
0.65% more ownership
Funds ownership: 101.92% → 102.57% (+0.65%)
1% less funds holding
Funds holding: 380 → 377 (-3)
5% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 40
11% less repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 146
66% less call options, than puts
Call options by funds: $21.1M | Put options by funds: $62M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$73.9M |
| 2 |
ClearBridge Investments
New York
|
+$36.3M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$36.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.6M |
| 5 |
Neuberger Berman Group
New York
|
+$20.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$29.9M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$21.3M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$9.39M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.92M |
| 5 |
BlackRock
New York
|
-$8.89M |
OMCL Hedge Fund Activity: Q2 2021 in Review
377 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2021, worth a combined $6.71B — up 18% from $5.7B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of OMCL and 38 opened new positions — a net loss of 2 holders — while 146 trimmed existing stakes and 130 added.
The largest buyer was Macquarie Group, adding an estimated $73.9M. The largest seller was Credit Suisse, cutting an estimated $29.9M.
- 377 institutional investors held Omnicell (OMCL) as of Q2 2021, down from 380 in Q1 2021.
- Funds reported $6.71B of Omnicell stock for Q2 2021, up 18% quarter-over-quarter.
- 38 funds opened new Omnicell positions in Q2 2021 and 40 closed out, a net change of -2 holders.
- The largest Omnicell buyer in Q2 2021 was Macquarie Group, an estimated $73.9M added.
- The largest Omnicell seller in Q2 2021 was Credit Suisse, an estimated $29.9M sold.
Based on aggregated 13F filings for Q2 2021.